Regina Hodits

Angelini Ventures has appointed Regina Hodits as managing director

Angelini Ventures has announced the appointment of Regina Hodits as its new managing director.

Hodits holds more than two decades of experience in venture capital, company creation and strategic exits across the biotechnology sector. She joins Angelini from Wellington Partners, where she served as managing director after joining the company over 15 years ago.

She also previously held leadership positions at Atlas Venture, Apax Partners and McKinsey & Company earlier in her career.

In her latest position, which will be based in Germany, Hodits will play a key role in defining Angelini’s international biotech investment strategy, and help identify and support innovation across therapeutics and biotech artificial intelligence.

Commenting on her latest venture, Hodits said: “I’m excited to work jointly with the colleagues at Angelini Ventures and to leverage the combined extensive network… to build the next generation of biotech leaders and help scale great science into impactful companies.”

Paolo Di Giorgio, chief executive officer and managing director of Angelini, added: “Regina’s scientific depth, extensive investment experience and exceptional track record in company-building make her a key addition to Angelini Ventures.”